Single-cell profiling of human CD127 + innate lymphoid cells reveals diverse immune phenotypes in hepatocellular carcinoma.

This in-depth understanding sheds light on B cell-driven innate type 2 inflammation and provides a potential strategy for HCC immunotherapy.